Experience Counts

Since 1987, MMG’s efforts have resulted in more than:

1,000,000

Patients screened

5,000

Sites engaged

2,500

Studies enrolled

70

Countries supported

700+

Oncology studies

100+

Rare/genetic disease studies

24

Gastroenterology studies

75

Neuroscience studies

36

Cardiology studies

100+

Pediatric studies

225

Infectious disease studies

93

Inflammatory disorder studies

Join “me” to close gaps in health equity and access

MMG’s “me” is a method powered by over 20 years of community-focused outreach to deliver clinical trial recruitment that overcomes the most critical enrollment barriers and achieves appropriate representation.

Describe Image Here

The most critical barriers to trial enrollment are transportation, financial burden, mistrust, education, and neglect.

MMG tackles each of these barriers with:

  • Travel concierge and payment services.
  • Plain language and multicultural clinical trial education materials, including videos and retention items
  • Training webinars and videos for sites
  • Direct outreach to trusted community leaders
  • Partnership for Access to Clinical Trials (PACT) program
  • Social listening and data mining to inform outreach placement

DCRI and MMG win Gold for Increasing Recruitment Diversity

Duke Clinical Research Institute (DCRI), in partnership with the Matthews Media Group Agency (MMG), received the MM+M Gold Award for the inclusion of diversity in clinical trial marketing. The objective of the MM+M Awards is to recognize, champion and celebrate creativity and effectiveness in healthcare marketing and communications.

An MM+M Award is valued because recognition comes from industry peers.

AI Solutions

Conversational AI replaces outdated patient engagement methods that are not effectively reaching patients.

The problem is friction

Why traditional engagement channels are not reaching patients:

  • 81% of patients do not pick up calls from unfamiliar phone numbers
  • 80% of e-mails go unopened
  • 90% of users do not open a healthcare app again after 30 days

Traditional methods have overestimated what patients will tolerate when it comes to communication channels.

Messaging dominates

Today’s preferred communication behaviors pivot around text messaging:

  • 80% of US adults use text messaging regularly
  • 97% of text messages are opened in less than 3 minutes

Language is the primary user interface

Conversational AI initiates patient engagement via text message and carries patients to IRB-compliant chat conversations that:

  • Require NO app downloads
  • Require NO usernames or passwords
  • Are mobile-first
  • Are simple and intuitive for all demographics

Tap into the power of Generative AI

Today’s innovations accelerate patient engagement by generating educational content more quickly and efficiently than ever before.

  • Create original video content 80% faster than with traditional methods
  • Reduce production costs by 75%
  • Increase viewer retention by up to 95%

Behind our strategies

There are no shortcuts. Every patient, site, protocol, country, and study timeline has different needs.

Participant Profile

Detailed profiles using multiple factors including diversity, prevalence, demographics, socioeconomic, behavior, and motivations

Global Insights

Incorporating insights that resonate with a global audience assessed though HCP and patient surveys, advisory groups, and market research

Study Landscape Analysis

Full analysis of the protocol, patient, and landscape using our proprietary 10-point Recruitment Difficulty Scale

Global Social Listening

Utilizing social network data, influencers, trusted sources, and communities to inform creative messaging and content

About MMG

Molly Matthews founded Matthews Media Group (MMG) in 1987 after a determined search to find a clinical trial option at the National Cancer Institute.

While her perseverance paid off for her family, she discovered a gap between life-changing clinical research and the patients and physicians who could benefit from it. Molly committed herself and MMG to closing that gap, and we are proud to advance the vision of clinical research as a care option.

Today, MMG is a proud member of the world's largest healthcare communications network, Omnicom Health Group (OHG).

The clinical trials we support benefit from our access to OHG's cutting-edge communication solutions and coveted partnerships in research, analytics, and digital technologies, as well as The Omnicom Group's vast buying power. We are privileged to scale these strengths to programs of all sizes.

Leadership

MMG's leadership team drives our relentless commitment to being the most trusted clinical trial patient engagement partner with patients, caregivers, healthcare providers, research sites, partners, and clients.

Ann Kottcamp

President

Kate Clarke

SVP, Finance

Government Contracts

MMG holds GSA MAS contract 470RAA22D006L.

NAICS Codes: 54163, 54181, 54910

MMG is a large business.

<

What our clients are saying

MMG's broad and deep knowledge has been very valuable. They connected sites, patients, monitors, and sponsor with ease and efficiency, which is particularly appreciated given our trial intricacies and many fast-moving parts.

CEO

Biotech

What sets MMG apart is commitment, collaboration, flexibility and ownership, and their openness to hearing and acting upon feedback in a professional and productive manner. They worked tirelessly to help us achieve our goals.

Associate Director

Clinical Development

MMG are very collaborative, efficient, and proactive in the way they manage in the way they manage all aspects of enrollment support materials development and delivery, especially on large, complex global studies.

Senior Scientist

Clinical Operations

Are you a patient looking for a clinical trial?

Please visit MyTrialSpot for a listing of trials supported by MMG. For a more complete directory of clinical trials please visit ClinicalTrials.gov.

Visit MyTrialSpot